| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |